HUMANIGEN INC SECURITIES SETTLEMENT

The purpose of this website is to advise members of the Settlement Class of the Settlement of the Action entitled In re Humanigen, Inc. Securities Litigation, Case No. 2:22-cv-05258 (the “Settlement”), now pending in the United States District Court of New Jersey.


The information contained on this web page is only a summary of information presented in more detail in the Notice of Pendency and Proposed Settlement of Class Action (the “Notice”), which you can access by clicking here. Since this website is just a summary, you should review the Notice for additional information.

If you are a Settlement Class Member, your legal rights will be affected by this Settlement whether you act or do not act.

Please read the Notice carefully.

IF YOU PURCHASED OR OTHERWISE ACQUIRED HUMANIGEN, INC. SECURITIES FROM MAY 16, 2020, TO JULY 12, 2022, YOU MAY BE A SETTLEMENT CLASS MEMBER.



YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT
SUBMIT A PROOF OF CLAIM AND RELEASE FORM POSTMARKED OR SUBMITTED ONLINE NO LATER THAN MARCH 7, 2024. The only way to get payment.
EXCLUDE YOURSELF FROM THE SETTLEMENT CLASS BY SUBMITTING A WRITTEN REQUEST FOR EXCLUSION POSTMARKED NO LATER THAN FEBRUARY 8, 2024. The deadline to exclude yourself from the Settlement has passed.
OBJECT TO THE SETTLEMENT BY SUBMITTING A WRITTEN OBJECTION POSTMARKED NO LATER THAN FEBRUARY 8, 2024. The deadline to object to the Settlement has passed.
DO NOTHING. Get no payment.


How Do I know if I am a Settlement Class Member?

The Court has preliminarily certified the following Settlement Class:

All persons and entities who purchased or otherwise acquired Humanigen, Inc. (“Humanigen”) securities from May 16, 2020, to July 12, 2022, inclusive. Excluded from the Settlement Class are: (i) Defendants; (ii) Officers, Directors, or affiliates of Humanigen; (iii) Humanigen’s employee retirement of benefit plan(s) or a participant or beneficiary to the extent they purchased or acquired Humanigen securities through any such plan(s); (iv) Any entity in which Defendants have or had controlling interest; (v) An immediate family member of any excluded person, which includes children, stepchildren, partners, stepparents, spouses, siblings, mothers-in-law, fathers-in-law, sons-in-law, daughters-in-law, brothers-in-law, and sisters-in-law; and (vi) A legal representative, heir, successor, or assign of any excluded person or entity. Also excluded from the Settlement Class will be any Persons who timely and validly seek exclusion from the Settlement Class in accordance with the requirements set by the Court.


The Settlement Hearing

On September 11, 2024, the Court granted final approval of Settlement and granted Plaintiffs’ motion for award of attorneys’ fees, reimbursement of litigation expenses and compensatory awards to Plaintiffs. Please find the relevant Orders in the Court Documents section of this website.


Further Information

This website and the Notice summarize the Settlement. For more details regarding the Settlement please reference the Stipulation of Settlement, and other documents filed in the case under the “Court Documents” link above. You may also contact the Claims Administrator or Lead Counsel for further information regarding the Settlement:

Claims Administrator:
HUMANIGEN INC. SECURITIES LITIGATION
Claims Administrator
c/o A.B. Data, Ltd.
P.O. Box 173107
Milwaukee, WI 53217
(877) 354-3785
info@HumanigenSecuritiesLitigation.com
Lead Counsel:
Adam M. Apton, Esq.
LEVI & KORSINSKY, LLP
33 Whitehall Street, 17th Floor
New York, New York 10004
aapton@zlk.com
Lead Counsel:
Jeremy A. Lieberman, Esq.
POMERANTZ LLP
600 3rd Avenue
New York, New York 10016
jalieberman@pomlaw.com



This website and the Notice summarize the Settlement. For more details regarding the Settlement please reference the Settlement Agreement, or other documents filed in the case under “Court Documents” in the navigation at the top. You may also contact the Claims Administrator or Lead Counsel for further information regarding the Settlement: